Wu D, Huang H, Chen T, Gai X, Li Q, Wang C
Cell Discov. 2023; 9(1):99.
PMID: 37789001
PMC: 10547766.
DOI: 10.1038/s41421-023-00590-8.
Pinedo-Carpio E, Dessapt J, Beneyton A, Sacre L, Berube M, Villot R
Sci Adv. 2023; 9(32):eadf4082.
PMID: 37556550
PMC: 10411901.
DOI: 10.1126/sciadv.adf4082.
Hromas R, Srinivasan G, Yang M, Jaiswal A, Totterdale T, Phillips L
iScience. 2022; 25(12):105626.
PMID: 36471805
PMC: 9719099.
DOI: 10.1016/j.isci.2022.105626.
Park D, Gharghabi M, Reczek C, Plow R, Yungvirt C, Aldaz C
Int J Mol Sci. 2022; 23(7).
PMID: 35409089
PMC: 8999063.
DOI: 10.3390/ijms23073729.
Jain A, McCoy M, Coats C, Brown S, Addya S, Pelz C
Cancers (Basel). 2022; 14(7).
PMID: 35406624
PMC: 8997573.
DOI: 10.3390/cancers14071848.
Two redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites.
Sherker A, Chaudhary N, Adam S, Heijink A, Noordermeer S, Fradet-Turcotte A
EMBO Rep. 2021; 22(12):e53679.
PMID: 34726323
PMC: 8647010.
DOI: 10.15252/embr.202153679.
The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus S, Stewart M, Klevit R
Biochem J. 2021; 478(18):3467-3483.
PMID: 34591954
PMC: 8763022.
DOI: 10.1042/BCJ20200864.
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
Krais J, Wang Y, Patel P, Basu J, Bernhardy A, Johnson N
Nat Commun. 2021; 12(1):5016.
PMID: 34408138
PMC: 8373961.
DOI: 10.1038/s41467-021-25346-4.
Role of matrix metalloproteinase-9 in neurodevelopmental deficits and experience-dependent plasticity in .
Gore S, James E, Huang L, Park J, Berghella A, Thompson A
Elife. 2021; 10.
PMID: 34282726
PMC: 8315794.
DOI: 10.7554/eLife.62147.
Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.
Leung E, Hazrati L
Brain Commun. 2021; 3(2):fcab117.
PMID: 34222870
PMC: 8242133.
DOI: 10.1093/braincomms/fcab117.
SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
Minten E, Kapoor-Vazirani P, Li C, Zhang H, Balakrishnan K, Yu D
Cell Rep. 2021; 34(13):108921.
PMID: 33789098
PMC: 8108010.
DOI: 10.1016/j.celrep.2021.108921.
A synergetic effect of BARD1 mutations on tumorigenesis.
Li W, Gu X, Liu C, Shi Y, Wang P, Zhang N
Nat Commun. 2021; 12(1):1243.
PMID: 33623049
PMC: 7902612.
DOI: 10.1038/s41467-021-21519-3.
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis.
Krais J, Johnson N
Cancer Res. 2020; 80(21):4601-4609.
PMID: 32747362
PMC: 7641968.
DOI: 10.1158/0008-5472.CAN-20-1830.
Literature Review of as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.
Alenezi W, Fierheller C, Recio N, Tonin P
Genes (Basel). 2020; 11(8).
PMID: 32726901
PMC: 7464855.
DOI: 10.3390/genes11080856.
in Breast and Ovarian Cancers.
Santana Dos Santos E, Lallemand F, Petitalot A, Caputo S, Rouleau E
Int J Mol Sci. 2020; 21(11).
PMID: 32481735
PMC: 7312125.
DOI: 10.3390/ijms21113850.
BRCA1 and homologous recombination: implications from mouse embryonic development.
Liu Y, Lu L
Cell Biosci. 2020; 10:49.
PMID: 32257107
PMC: 7106644.
DOI: 10.1186/s13578-020-00412-4.
53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice.
Chen J, Li P, Song L, Bai L, Huen M, Liu Y
Cell Death Differ. 2020; 27(9):2552-2567.
PMID: 32139898
PMC: 7429965.
DOI: 10.1038/s41418-020-0521-4.
How to Inactivate Human Ubiquitin E3 Ligases by Mutation.
Garcia-Barcena C, Osinalde N, Ramirez J, Mayor U
Front Cell Dev Biol. 2020; 8:39.
PMID: 32117970
PMC: 7010608.
DOI: 10.3389/fcell.2020.00039.
TRAIP is a master regulator of DNA interstrand crosslink repair.
Wu R, Semlow D, Kamimae-Lanning A, Kochenova O, Chistol G, Hodskinson M
Nature. 2019; 567(7747):267-272.
PMID: 30842657
PMC: 6417926.
DOI: 10.1038/s41586-019-1002-0.
GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.
Caleca L, Colombo M, Hansen T, Lazaro C, Manoukian S, Parsons M
Cancers (Basel). 2019; 11(2).
PMID: 30696104
PMC: 6406614.
DOI: 10.3390/cancers11020151.